Integra LifeSciences (IART) Competitors $22.88 -0.39 (-1.68%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IART vs. MDXG, NARI, ICUI, ITGR, ATRC, ATEC, OFIX, SRDX, ANGO, and ARAYShould you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include MiMedx Group (MDXG), Inari Medical (NARI), ICU Medical (ICUI), Integer (ITGR), AtriCure (ATRC), Alphatec (ATEC), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), and Accuray (ARAY). These companies are all part of the "medical" sector. Integra LifeSciences vs. MiMedx Group Inari Medical ICU Medical Integer AtriCure Alphatec Orthofix Medical Surmodics AngioDynamics Accuray MiMedx Group (NASDAQ:MDXG) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership. Which has preferable earnings & valuation, MDXG or IART? Integra LifeSciences has higher revenue and earnings than MiMedx Group. Integra LifeSciences is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMiMedx Group$342.80M3.98$58.23M$0.5516.87Integra LifeSciences$1.56B1.13$67.74M-$0.09-254.22 Does the MarketBeat Community believe in MDXG or IART? Integra LifeSciences received 392 more outperform votes than MiMedx Group when rated by MarketBeat users. However, 81.82% of users gave MiMedx Group an outperform vote while only 56.90% of users gave Integra LifeSciences an outperform vote. CompanyUnderperformOutperformMiMedx GroupOutperform Votes4581.82% Underperform Votes1018.18%Integra LifeSciencesOutperform Votes43756.90% Underperform Votes33143.10% Which has more risk & volatility, MDXG or IART? MiMedx Group has a beta of 1.94, meaning that its stock price is 94% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Do analysts rate MDXG or IART? MiMedx Group currently has a consensus price target of $12.00, suggesting a potential upside of 29.31%. Integra LifeSciences has a consensus price target of $24.00, suggesting a potential upside of 4.90%. Given MiMedx Group's stronger consensus rating and higher possible upside, equities analysts clearly believe MiMedx Group is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Integra LifeSciences 3 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75 Do institutionals & insiders hold more shares of MDXG or IART? 79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 1.3% of MiMedx Group shares are owned by insiders. Comparatively, 3.1% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is MDXG or IART more profitable? MiMedx Group has a net margin of 23.86% compared to Integra LifeSciences' net margin of -0.42%. MiMedx Group's return on equity of 26.21% beat Integra LifeSciences' return on equity.Company Net Margins Return on Equity Return on Assets MiMedx Group23.86% 26.21% 18.15% Integra LifeSciences -0.42%12.35%4.82% Does the media refer more to MDXG or IART? In the previous week, MiMedx Group had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 9 mentions for MiMedx Group and 5 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.27 beat MiMedx Group's score of 0.64 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMiMedx Group beats Integra LifeSciences on 12 of the 18 factors compared between the two stocks. Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IART vs. The Competition Export to ExcelMetricIntegra LifeSciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.77B$4.56B$5.07B$8.66BDividend YieldN/A39.56%5.09%4.06%P/E Ratio-254.1925.28101.9417.40Price / Sales1.1355.051,197.2969.07Price / Cash4.8351.7440.9636.36Price / Book1.165.486.335.87Net Income$67.74M$13.76M$119.64M$225.66M7 Day Performance-7.67%-6.52%-5.13%-1.34%1 Month Performance15.79%2.19%-2.72%1.15%1 Year Performance-40.95%50.62%31.06%24.02% Integra LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IARTIntegra LifeSciences2.9858 of 5 stars$22.88-1.7%$24.00+4.9%-41.5%$1.77B$1.54B-254.193,946Positive NewsMDXGMiMedx Group3.0319 of 5 stars$9.28+0.5%N/A+38.5%$1.36B$342.80M16.87895News CoverageHigh Trading VolumeNARIInari Medical3.3224 of 5 stars$50.56+2.7%N/A-14.3%$2.96B$574.50M-37.451,300Positive NewsICUIICU Medical4.1554 of 5 stars$167.86-2.4%N/A+92.7%$4.11B$2.34B-36.7314,000Analyst DowngradeShort Interest ↓News CoverageITGRInteger3.3599 of 5 stars$133.18-1.2%N/A+49.6%$4.47B$1.60B41.1010,500Analyst RevisionNews CoveragePositive NewsATRCAtriCure3.5183 of 5 stars$35.03-0.8%N/A-16.5%$1.71B$447.57M-42.201,200Short Interest ↓Positive NewsATECAlphatec4.3723 of 5 stars$8.23-5.7%N/A-27.7%$1.17B$572.74M-6.43700OFIXOrthofix Medical2.0849 of 5 stars$18.08+2.7%N/A+74.0%$690.20M$784.25M-5.781,634Gap UpSRDXSurmodics4.3381 of 5 stars$38.72+1.7%N/A+13.8%$552.42M$126.08M-47.80376Analyst ForecastPositive NewsANGOAngioDynamics4.7805 of 5 stars$6.81-0.6%N/A-0.7%$276.72M$292.73M-1.12748Short Interest ↓News CoveragePositive NewsARAYAccuray4.6538 of 5 stars$1.70-2.3%N/A-32.5%$170.96M$444.20M-10.00987Analyst Downgrade Related Companies and Tools Related Companies MDXG Alternatives NARI Alternatives ICUI Alternatives ITGR Alternatives ATRC Alternatives ATEC Alternatives OFIX Alternatives SRDX Alternatives ANGO Alternatives ARAY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IART) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
